Literature DB >> 1315416

Primary human herpesvirus 6 infection in young children.

P Pruksananonda1, C B Hall, R A Insel, K McIntyre, P E Pellett, C E Long, K C Schnabel, P H Pincus, F R Stamey, T R Dambaugh.   

Abstract

BACKGROUND: Human herpesvirus 6 (HHV-6) is a recently discovered virus that, on the basis of serologic evidence, appears to infect most children by the age of three years. However, the clinical manifestations of primary HHV-6 infection have not been well defined.
METHODS: We studied consecutive children two years old or younger who presented to an emergency ward with febrile illnesses. Our evaluation included the isolation of HHV-6 from peripheral-blood mononuclear cells, an immunofluorescent-antibody assay, the detection of HHV-6 by the polymerase chain reaction (PCR), and restriction-endonuclease-fragment profiles of HHV-6 isolates.
RESULTS: HHV-6 was isolated from 34 of 243 acutely ill children (14 percent). The children with viremia had irritability, high temperatures (mean, 39.7 degrees C), and inflammation of tympanic membranes (in 21), but few other localizing signs. Two children were hospitalized, but all 34 recovered after an average of four days of fever. The rash characteristic of roseola, which has been associated with HHV-6 infection, was noted in only three children. In 29 children (85 percent), serum samples obtained during convalescence had at least a fourfold increase in IgG antibody titers; 4 infants less than three months old who presumably had maternal antibody did not have this increase. HHV-6 was isolated from blood obtained during convalescence in only one child, but in two thirds of the children the virus could be detected by PCR. The isolates had genomic heterogeneity, indicating the presence of multiple strains.
CONCLUSIONS: Primary infection with HHV-6 is a major cause of acute febrile illness in young children. Such infection is associated with varied clinical manifestations, viremia, and the frequent persistence of the viral genome in mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315416     DOI: 10.1056/NEJM199205283262201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  48 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  And then there were eight...

Authors:  S D Shafran; J M Conly
Journal:  Can J Infect Dis       Date:  1996-01

3.  Disease association and diagnosis of human herpesvirus 6.

Authors:  J Weber; G Wilson
Journal:  Can J Infect Dis       Date:  1994-07

4.  Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases.

Authors:  M Luppi; P Barozzi; R Garber; A Maiorana; G Bonacorsi; T Artusi; R Trovato; R Marasca; G Torelli
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Temporal mapping of transcripts in herpesvirus 6 variants.

Authors:  P Mirandola; P Menegazzi; S Merighi; T Ravaioli; E Cassai; D Di Luca
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 6.  Human herpesvirus-6 infections.

Authors:  C A Jones; D Isaacs
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

7.  Detection of human herpesviruses 6 and 7 genomic sequences in brain tumours.

Authors:  P K Chan; H K Ng; A F Cheng
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

8.  Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7.

Authors:  D Skrincosky; P Hocknell; L Whetter; P Secchiero; B Chandran; S Dewhurst
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Quantitative PCR for human herpesviruses 6 and 7.

Authors:  P Secchiero; D Zella; R W Crowley; R C Gallo; P Lusso
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

Review 10.  Human herpesvirus 6 infections after liver transplantation.

Authors:  Rima Camille Abdel Massih; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.